April 23, 2024
The collapse of a massive deal to settle claims Eli Lilly illegally inflated insulin prices may not alter the trajectory of the underlying litigation, as patients are already pressing ahead with a new version of their proposed class action.
April 16, 2024
Eli Lilly & Co. and insulin buyers have called off a proposed nationwide settlement that would've capped insulin prices and been worth up to $500 million over several years, a decision that was made after the buyers lost a class certification bid early this year, according to the buyers' counsel.
May 26, 2023
Insulin buyers asked a New Jersey federal judge Friday to greenlight a class settlement with Eli Lilly & Co. resolving claims it schemed to drive up insulin drug prices, a deal that includes $13.5 million cash and insulin price caps which plaintiffs' lawyers value at $500 million over four years.